Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Sinorhizobium medicae 50S ribosomal protein L21 (rplU) CSB-YP410213STV
CSB-EP410213STV
CSB-BP410213STV
CSB-MP410213STV
CSB-EP410213STV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sinorhizobium medicae Ribosomal RNA large subunit methyltransferase H (rlmH) CSB-YP410214STV
CSB-EP410214STV
CSB-BP410214STV
CSB-MP410214STV
CSB-EP410214STV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sinorhizobium medicae Ribosome maturation factor RimM (rimM) CSB-YP410215STV
CSB-EP410215STV
CSB-BP410215STV
CSB-MP410215STV
CSB-EP410215STV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sinorhizobium medicae Protein-export protein secB (secB) CSB-YP410216STV
CSB-EP410216STV
CSB-BP410216STV
CSB-MP410216STV
CSB-EP410216STV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sinorhizobium medicae 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase (gpmA) CSB-YP410217STV
CSB-EP410217STV
CSB-BP410217STV
CSB-MP410217STV
CSB-EP410217STV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sinorhizobium medicae Polyribonucleotide nucleotidyltransferase (pnp), partial CSB-YP410218STV
CSB-EP410218STV
CSB-BP410218STV
CSB-MP410218STV
CSB-EP410218STV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sinorhizobium medicae 50S ribosomal protein L20 (rplT) CSB-YP410219STV
CSB-EP410219STV
CSB-BP410219STV
CSB-MP410219STV
CSB-EP410219STV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sinorhizobium medicae C4-dicarboxylate transport protein (dctA), partial CSB-YP410220STV
CSB-EP410220STV
CSB-BP410220STV
CSB-MP410220STV
CSB-EP410220STV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sinorhizobium medicae Cbb3-type cytochrome c oxidase subunit FixP (fixP), partial CSB-YP410221STV
CSB-EP410221STV
CSB-BP410221STV
CSB-MP410221STV
CSB-EP410221STV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus vannielii FO synthase subunit 1 (cofG) CSB-YP410222MNS
CSB-EP410222MNS
CSB-BP410222MNS
CSB-MP410222MNS
CSB-EP410222MNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus vannielii Probable chemoreceptor glutamine deamidase CheD (cheD) CSB-YP410223MNS
CSB-EP410223MNS
CSB-BP410223MNS
CSB-MP410223MNS
CSB-EP410223MNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus vannielii V-type ATP synthase subunit F (atpF) CSB-YP410224MNS
CSB-EP410224MNS
CSB-BP410224MNS
CSB-MP410224MNS
CSB-EP410224MNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus vannielii Cysteine--tRNA ligase (cysS) CSB-YP410225MNS
CSB-EP410225MNS
CSB-BP410225MNS
CSB-MP410225MNS
CSB-EP410225MNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus vannielii Thiamine-phosphate synthase (thiE) CSB-YP410226MNS
CSB-EP410226MNS
CSB-BP410226MNS
CSB-MP410226MNS
CSB-EP410226MNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus vannielii L-fuculose phosphate aldolase (fucA) CSB-YP410227MNS
CSB-EP410227MNS
CSB-BP410227MNS
CSB-MP410227MNS
CSB-EP410227MNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus vannielii UPF0280 protein Mevan_0550 (Mevan_0550) CSB-YP410228MNS
CSB-EP410228MNS
CSB-BP410228MNS
CSB-MP410228MNS
CSB-EP410228MNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus vannielii Glutamyl-tRNA (Gln) amidotransferase subunit E, partial CSB-YP410229MNS
CSB-EP410229MNS
CSB-BP410229MNS
CSB-MP410229MNS
CSB-EP410229MNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus vannielii UPF0095 protein Mevan_0596 (Mevan_0596) CSB-YP410230MNS
CSB-EP410230MNS
CSB-BP410230MNS
CSB-MP410230MNS
CSB-EP410230MNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus vannielii Elongation factor 1-beta (ef1b) CSB-YP410231MNS
CSB-EP410231MNS
CSB-BP410231MNS
CSB-MP410231MNS
CSB-EP410231MNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus vannielii 30S ribosomal protein S4e (rps4e) CSB-YP410232MNS
CSB-EP410232MNS
CSB-BP410232MNS
CSB-MP410232MNS
CSB-EP410232MNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>